Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis.
about
Beclometasone for chronic obstructive pulmonary diseaseInhaled steroids and risk of pneumonia for chronic obstructive pulmonary diseaseCombined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary diseaseBeclometasone for COPDOverview of the pharmacological challenges facing physicians in the management of patients with concomitant cardiovascular disease and chronic obstructive pulmonary diseaseSirtuin 1 and aging theory for chronic obstructive pulmonary diseaseEfficacy and safety of inhaler steroids in COPD patients: Systematic review and meta-analysis of randomized placebo-controlled trialsRespiratory impairment and the aging lung: a novel paradigm for assessing pulmonary functionEffects of two Chinese herbal formulae for the treatment of moderate to severe stable chronic obstructive pulmonary disease: a multicenter, double-blind, randomized controlled trialThe best of respiratory infections from the 2015 European Respiratory Society International CongressCommon Infections in Patients Prescribed Systemic Glucocorticoids in Primary Care: A Population-Based Cohort StudyGlucocorticoid insensitivity as a future target of therapy for chronic obstructive pulmonary diseaseThe Effect of Incidental Consolidation on Management and Outcomes in COPD Exacerbations: Data from the European COPD AuditCopd.Relationship between the use of inhaled steroids for chronic respiratory diseases and early outcomes in community-acquired pneumonia.Extrafine beclomethasone/formoterol compared to fluticasone/salmeterol combination therapy in COPDPharmacotherapy and the risk for community-acquired pneumonia."Causes of death in asthma, COPD and non-respiratory hospitalized patients: a multicentric study".Risk of pneumonia with inhaled corticosteroid versus long-acting bronchodilator regimens in chronic obstructive pulmonary disease: a new-user cohort study.Inhaled Corticosteroid use and the Risk of Pneumonia and COPD Exacerbations in the UPLIFT Study.Chronic obstructive pulmonary disease treated with inhaled medium- or high-dose corticosteroids: a prospective and randomized study focusing on clinical efficacy and the risk of pneumonia.Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma.Effects of inhaled corticosteroids on pneumonia severity and antimicrobial resistance.Risk of pneumonia in obstructive lung disease: A real-life study comparing extra-fine and fine-particle inhaled corticosteroids.Chronic obstructive pulmonary disease in older persons: A comparison of two spirometric definitionsHIV-associated obstructive lung diseases: insights and implications for the clinician.Influencing the decline of lung function in COPD: use of pharmacotherapy.Risk of pneumonia associated with long-term use of inhaled corticosteroids in chronic obstructive pulmonary disease: a critical review and updateElevated placenta growth factor predicts pneumonia in patients with chronic obstructive pulmonary disease under inhaled corticosteroids therapy.Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro-con perspective.An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary disease.Suppressed expression of T-box transcription factors is involved in senescence in chronic obstructive pulmonary disease.Risk of herpes zoster among patients with chronic obstructive pulmonary disease: a population-based study.Update on pharmaceutical and minimally invasive management strategies for chronic obstructive pulmonary disease.Scientific respiratory symposium, paris june 2010Improvement of Airflow Limitation by Fluticasone Propionate/Salmeterol in Chronic Obstructive Pulmonary Disease: What is the Specific Marker?Increased incidence of invasive bacterial disease in chronic obstructive pulmonary disease compared to the general population--a population based cohort study.The ratio of FEV1 to FVC as a basis for establishing chronic obstructive pulmonary diseaseObservational study of inhaled corticosteroids on outcomes for COPD patients with pneumonia.Withdrawal of inhaled corticosteroids in individuals with COPD--a systematic review and comment on trial methodology.
P2860
Q24197535-93C39EDF-907E-4E96-90B7-E2565B293E4FQ24197989-AFD05B4B-4864-4B31-934F-E95E399A9A1EQ24199130-723EE3B1-1436-4B97-AA66-1678330BB156Q24200572-A801E6B3-1B5D-482B-B9D4-EC2E81497E35Q26741051-6CB2828E-8D43-4A50-ABCC-90044F27E902Q26799889-E3CC47DF-7103-49C7-91E9-E7D8BFE57C72Q27025647-501428F1-3DE4-4FBB-8A0C-0EDC0858EF18Q28397453-99A0933D-2D5A-4128-9B12-ACB1A9297684Q28541874-495C38B1-1478-4843-967E-FF46C4F1AE25Q28598393-DC7184A3-067D-41AF-9B18-D0C2FEDF446EQ28602277-2E668AC1-461E-4DEE-88E3-CBF296388BADQ28761895-C18922B1-A92E-4D6C-85E0-1DF92B413F5DQ30982948-3A2ED011-CBFE-4ED6-BD3E-E288CA94BECFQ31016356-D1462D91-DF03-460C-BBCB-426E7509DEB4Q31138448-2CF76D2E-91B5-4ED2-8A7B-7D3664ECFBF4Q33558856-5053E629-8249-4A99-8F70-43B45998A91DQ33626068-99B7C73B-E5CB-4072-8949-545D7B6B03E1Q33643053-B638B3C4-C407-4228-9FC6-EA1CC72E1A1AQ33689926-6D3ABAA3-8C49-4BC5-88C9-265ECC0C93A8Q33705358-DC8C9604-EC1F-4D19-A5F5-36D8D078361EQ33709357-AF42DAEB-B5C0-4561-A29A-9BDBE420E9C3Q33782854-C4DAC068-211A-436A-ABF8-88A0693D26FBQ33790645-EA5302C3-2B9A-48D7-9B04-A70AF1D143C8Q33803143-37962A38-DB56-494C-B95F-C2DAF457F128Q33931328-46E2F853-FCF8-4A41-B865-B6FDF62D16F5Q33950594-070278AC-8640-46A5-A417-9D8717B33000Q33966001-39EC5E9D-8CF8-436D-B663-BC6C6B9D0088Q34015461-D950158C-F71D-4F26-9906-B23C20A463D0Q34036358-0767FC53-17E0-4C56-9EF4-CF879BF080CBQ34065276-34B17D21-D29B-43E0-B094-C04B17C0A615Q34065958-AF9AE20E-B9F9-4BE0-967E-D537759D768CQ34350843-BC64BE96-7888-4A4D-AC2F-37720E062B70Q34693477-1275B928-99C5-4C76-8BC8-18E334E1CAF6Q35028812-379C6CC9-4520-42C1-870D-5A7A301C5A51Q35117833-8F64F6D7-9CAC-4CB6-A99F-82DD4A05DDBAQ35119108-87C14F13-14C7-47A5-9F41-BED941E3264AQ35128794-07BD2BDC-07AE-472E-A002-8C4EC9E905A7Q35173527-6E18F09A-6656-4F58-BEE0-1DC3A2C58419Q35219711-007C3363-AD7B-4B58-B126-71E2C06CEDF6Q35257612-3A6CDE6C-BD9C-490F-BF6B-C348C8D99269
P2860
Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis.
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Inhaled corticosteroids in pat ...... atic review and meta-analysis.
@ast
Inhaled corticosteroids in pat ...... atic review and meta-analysis.
@en
Inhaled corticosteroids in pat ...... atic review and meta-analysis.
@nl
type
label
Inhaled corticosteroids in pat ...... atic review and meta-analysis.
@ast
Inhaled corticosteroids in pat ...... atic review and meta-analysis.
@en
Inhaled corticosteroids in pat ...... atic review and meta-analysis.
@nl
prefLabel
Inhaled corticosteroids in pat ...... atic review and meta-analysis.
@ast
Inhaled corticosteroids in pat ...... atic review and meta-analysis.
@en
Inhaled corticosteroids in pat ...... atic review and meta-analysis.
@nl
P2093
P2860
P921
P356
P1476
Inhaled corticosteroids in pat ...... atic review and meta-analysis.
@en
P2093
David J Murphy
M Bradley Drummond
Marshall W Pitz
P2860
P304
P356
10.1001/JAMA.2008.717
P407
P577
2008-11-01T00:00:00Z